Package Quantity: 50/Pkg Active Ingredient: Verdinexor Presentation: Tablet Strength: 50 mg
Quantity
Choose a comparable product or call 1-800-225-7911 for assistance

Laverdia™-CA1 is the first oral tablet FDA conditionally approved to treat lymphoma in dogs.

  • Verdinexor is a selective inhibitor of nuclear export CRM1/XPO1 protein
  • The active ingredient in Laverdia-CA1 is verdinexor, a substance that works by preventing tumor suppressing proteins from leaving the nucleus of cells, resulting in disruption of cancer cell survival and eventual cancer cell death

Package Quantity: 50/Pkg Active Ingredient: Verdinexor Presentation: Tablet Strength: 50 mg NDC Number: 86121-0003-01 Container Type: Bottle For Animal Type: Dog Pill Count: 50/Pkg NDC Number: 86121-0003-01